Researchers are exploring the use of ultrasound to trigger the release of chemotherapeutic drugs from gold nanoparticles. This technology is part of a broader field of research into targeted cancer therapy using nanoplatforms and stimuli-responsive biomaterials. The approach is being investigated through various methods, including computational modeling and experimental studies using different types of nanoparticles and delivery systems.